There were 523 press releases posted in the last 24 hours and 166,640 in the last 365 days.

Global Glaucoma Pharmaceuticals Industry

Glaucoma Pharmaceuticals market worldwide is projected to grow by US$1. 3 Billion, driven by a compounded growth of 3%. Hospitals, one of the segments analyzed and sized in this study, displays the potential to grow at over 3.

/EIN News/ -- New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Glaucoma Pharmaceuticals Industry" - https://www.reportlinker.com/p05817992/?utm_source=GNW
2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$4.4 Billion by the year 2025, Hospitals will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 2.3% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$50.8 Million to the region’s size and clout in the next 5 to 6 years. Over US$40.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Hospitals will reach a market size of US$263.6 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 4.5% over the next couple of years and add approximately US$361.9 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, Aerie Pharmaceuticals, Inc.; Allergan PLC; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.; Santen Pharmaceuticals Co., Ltd.


Read the full report: https://www.reportlinker.com/p05817992/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Glaucoma Pharmaceuticals Competitor Market Share Scenario
Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Glaucoma Pharmaceuticals Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Glaucoma Pharmaceuticals Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Glaucoma Pharmaceuticals Market Share Shift across Key
Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Hospitals (End-Use) Global Opportunity Assessment in
US$ Million by Region/Country: 2018-2025
Table 5: Hospitals (End-Use) Historic Sales Analysis in US$
Million by Region/Country: 2009-2017
Table 6: Hospitals (End-Use) Percentage Share Breakdown of
Global Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Ophthalmic Clinics (End-Use) Worldwide Sales in US$
Million by Region/Country: 2018-2025
Table 8: Ophthalmic Clinics (End-Use) Historic Demand Patterns
in US$ Million by Region/Country: 2009-2017
Table 9: Ophthalmic Clinics (End-Use) Market Share Shift across
Key Geographies: 2009 VS 2019 VS 2025
Table 10: Ambulatory Surgical Centers (End-Use) Global Market
Estimates & Forecasts in US$ Million by Region/Country:
2018-2025
Table 11: Ambulatory Surgical Centers (End-Use) Retrospective
Demand Analysis in US$ Million by Region/Country: 2009-2017
Table 12: Ambulatory Surgical Centers (End-Use) Market Share
Breakdown by Region/Country: 2009 VS 2019 VS 2025
Table 13: Prostaglandins (Drug Class) World Market Estimates
and Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 14: Prostaglandins (Drug Class) Market Historic Review by
Region/Country in US$ Million: 2009 to 2017
Table 15: Prostaglandins (Drug Class) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Beta Blockers (Drug Class) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 17: Beta Blockers (Drug Class) Historic Market Analysis
by Region/Country in US$ Million: 2009 to 2017
Table 18: Beta Blockers (Drug Class) Market Share Distribution
in Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 19: Alpha Agonists (Drug Class) World Market Estimates
and Forecasts in US$ Million by Region/Country: 2018 to 2025
Table 20: Alpha Agonists (Drug Class) Market Worldwide Historic
Review by Region/Country in US$ Million: 2009 to 2017
Table 21: Alpha Agonists (Drug Class) Market Percentage Share
Distribution by Region/Country: 2009 VS 2019 VS 2025
Table 22: Carbonic Anhydrase Inhibitors (Drug Class) Market
Opportunity Analysis Worldwide in US$ Million by
Region/Country: 2018 to 2025
Table 23: Carbonic Anhydrase Inhibitors (Drug Class) Global
Historic Demand in US$ Million by Region/Country: 2009 to 2017
Table 24: Carbonic Anhydrase Inhibitors (Drug Class) Market
Share Distribution in Percentage by Region/Country: 2009 VS
2019 VS 2025
Table 25: Combination Medications (Drug Class) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 26: Combination Medications (Drug Class) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 27: Combination Medications (Drug Class) Market Share
Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS
2025
Table 28: Cholinergics (Drug Class) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 29: Cholinergics (Drug Class) Historic Market Perspective
by Region/Country in US$ Million: 2009 to 2017
Table 30: Cholinergics (Drug Class) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Glaucoma Pharmaceuticals Market Share (in %) by Company:
2019 & 2025
Table 31: United States Glaucoma Pharmaceuticals Latent Demand
Forecasts in US$ Million by End-Use: 2018 to 2025
Table 32: Glaucoma Pharmaceuticals Historic Demand Patterns in
the United States by End-Use in US$ Million for 2009-2017
Table 33: Glaucoma Pharmaceuticals Market Share Breakdown in
the United States by End-Use: 2009 VS 2019 VS 2025
Table 34: United States Glaucoma Pharmaceuticals Market
Estimates and Projections in US$ Million by Drug Class: 2018 to
2025
Table 35: Glaucoma Pharmaceuticals Market in the United States
by Drug Class: A Historic Review in US$ Million for 2009-2017
Table 36: United States Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
CANADA
Table 37: Canadian Glaucoma Pharmaceuticals Market Quantitative
Demand Analysis in US$ Million by End-Use: 2018 to 2025
Table 38: Glaucoma Pharmaceuticals Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 39: Canadian Glaucoma Pharmaceuticals Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
Table 40: Canadian Glaucoma Pharmaceuticals Market Estimates
and Forecasts in US$ Million by Drug Class: 2018 to 2025
Table 41: Canadian Glaucoma Pharmaceuticals Historic Market
Review by Drug Class in US$ Million: 2009-2017
Table 42: Glaucoma Pharmaceuticals Market in Canada: Percentage
Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
JAPAN
Table 43: Japanese Demand Estimates and Forecasts for Glaucoma
Pharmaceuticals in US$ Million by End-Use: 2018 to 2025
Table 44: Japanese Glaucoma Pharmaceuticals Market in US$
Million by End-Use: 2009-2017
Table 45: Glaucoma Pharmaceuticals Market Share Shift in Japan
by End-Use: 2009 VS 2019 VS 2025
Table 46: Japanese Market for Glaucoma Pharmaceuticals: Annual
Sales Estimates and Projections in US$ Million by Drug Class
for the Period 2018-2025
Table 47: Glaucoma Pharmaceuticals Market in Japan: Historic
Sales Analysis in US$ Million by Drug Class for the Period
2009-2017
Table 48: Japanese Glaucoma Pharmaceuticals Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
CHINA
Table 49: Chinese Demand for Glaucoma Pharmaceuticals in US$
Million by End-Use: 2018 to 2025
Table 50: Glaucoma Pharmaceuticals Market Review in China in
US$ Million by End-Use: 2009-2017
Table 51: Chinese Glaucoma Pharmaceuticals Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
Table 52: Chinese Glaucoma Pharmaceuticals Market Growth
Prospects in US$ Million by Drug Class for the Period 2018-2025
Table 53: Glaucoma Pharmaceuticals Historic Market Analysis in
China in US$ Million by Drug Class: 2009-2017
Table 54: Chinese Glaucoma Pharmaceuticals Market by Drug
Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Glaucoma Pharmaceuticals Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 55: European Glaucoma Pharmaceuticals Market Demand
Scenario in US$ Million by Region/Country: 2018-2025
Table 56: Glaucoma Pharmaceuticals Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2009-2017
Table 57: European Glaucoma Pharmaceuticals Market Share Shift
by Region/Country: 2009 VS 2019 VS 2025
Table 58: European Glaucoma Pharmaceuticals Addressable Market
Opportunity in US$ Million by End-Use: 2018-2025
Table 59: Glaucoma Pharmaceuticals Market in Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 60: European Glaucoma Pharmaceuticals Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
Table 61: European Glaucoma Pharmaceuticals Market Estimates
and Forecasts in US$ Million by Drug Class: 2018-2025
Table 62: Glaucoma Pharmaceuticals Market in Europe in US$
Million by Drug Class: A Historic Review for the Period
2009-2017
Table 63: European Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
FRANCE
Table 64: Glaucoma Pharmaceuticals Quantitative Demand Analysis
in France in US$ Million by End-Use: 2018-2025
Table 65: French Glaucoma Pharmaceuticals Historic Market
Review in US$ Million by End-Use: 2009-2017
Table 66: French Glaucoma Pharmaceuticals Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
Table 67: Glaucoma Pharmaceuticals Market in France by Drug
Class: Estimates and Projections in US$ Million for the Period
2018-2025
Table 68: French Glaucoma Pharmaceuticals Historic Market
Scenario in US$ Million by Drug Class: 2009-2017
Table 69: French Glaucoma Pharmaceuticals Market Share Analysis
by Drug Class: 2009 VS 2019 VS 2025
GERMANY
Table 70: Glaucoma Pharmaceuticals Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2018-2025
Table 71: German Glaucoma Pharmaceuticals Market in Retrospect
in US$ Million by End-Use: 2009-2017
Table 72: Glaucoma Pharmaceuticals Market Share Distribution in
Germany by End-Use: 2009 VS 2019 VS 2025
Table 73: Glaucoma Pharmaceuticals Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Drug Class
for the Period 2018-2025
Table 74: German Glaucoma Pharmaceuticals Historic Market
Analysis in US$ Million by Drug Class: 2009-2017
Table 75: German Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
ITALY
Table 76: Italian Demand for Glaucoma Pharmaceuticals in US$
Million by End-Use: 2018 to 2025
Table 77: Glaucoma Pharmaceuticals Market Review in Italy in
US$ Million by End-Use: 2009-2017
Table 78: Italian Glaucoma Pharmaceuticals Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
Table 79: Italian Glaucoma Pharmaceuticals Market Growth
Prospects in US$ Million by Drug Class for the Period 2018-2025
Table 80: Glaucoma Pharmaceuticals Historic Market Analysis in
Italy in US$ Million by Drug Class: 2009-2017
Table 81: Italian Glaucoma Pharmaceuticals Market by Drug
Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 82: United Kingdom Demand Estimates and Forecasts for
Glaucoma Pharmaceuticals in US$ Million by End-Use: 2018 to
2025
Table 83: United Kingdom Glaucoma Pharmaceuticals Market in US$
Million by End-Use: 2009-2017
Table 84: Glaucoma Pharmaceuticals Market Share Shift in the
United Kingdom by End-Use: 2009 VS 2019 VS 2025
Table 85: United Kingdom Market for Glaucoma Pharmaceuticals:
Annual Sales Estimates and Projections in US$ Million by Drug
Class for the Period 2018-2025
Table 86: Glaucoma Pharmaceuticals Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Drug Class
for the Period 2009-2017
Table 87: United Kingdom Glaucoma Pharmaceuticals Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
SPAIN
Table 88: Spanish Glaucoma Pharmaceuticals Market Quantitative
Demand Analysis in US$ Million by End-Use: 2018 to 2025
Table 89: Glaucoma Pharmaceuticals Market in Spain:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 90: Spanish Glaucoma Pharmaceuticals Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
Table 91: Spanish Glaucoma Pharmaceuticals Market Estimates and
Forecasts in US$ Million by Drug Class: 2018 to 2025
Table 92: Spanish Glaucoma Pharmaceuticals Historic Market
Review by Drug Class in US$ Million: 2009-2017
Table 93: Glaucoma Pharmaceuticals Market in Spain: Percentage
Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
RUSSIA
Table 94: Russian Glaucoma Pharmaceuticals Latent Demand
Forecasts in US$ Million by End-Use: 2018 to 2025
Table 95: Glaucoma Pharmaceuticals Historic Demand Patterns in
Russia by End-Use in US$ Million for 2009-2017
Table 96: Glaucoma Pharmaceuticals Market Share Breakdown in
Russia by End-Use: 2009 VS 2019 VS 2025
Table 97: Russian Glaucoma Pharmaceuticals Market Estimates and
Projections in US$ Million by Drug Class: 2018 to 2025
Table 98: Glaucoma Pharmaceuticals Market in Russia by Drug
Class: A Historic Review in US$ Million for 2009-2017
Table 99: Russian Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 100: Rest of Europe Glaucoma Pharmaceuticals Addressable
Market Opportunity in US$ Million by End-Use: 2018-2025
Table 101: Glaucoma Pharmaceuticals Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 102: Rest of Europe Glaucoma Pharmaceuticals Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
Table 103: Rest of Europe Glaucoma Pharmaceuticals Market
Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
Table 104: Glaucoma Pharmaceuticals Market in Rest of Europe in
US$ Million by Drug Class: A Historic Review for the Period
2009-2017
Table 105: Rest of Europe Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 106: Asia-Pacific Glaucoma Pharmaceuticals Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 107: Glaucoma Pharmaceuticals Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2009-2017
Table 108: Asia-Pacific Glaucoma Pharmaceuticals Market Share
Analysis by Region/Country: 2009 VS 2019 VS 2025
Table 109: Glaucoma Pharmaceuticals Quantitative Demand
Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
Table 110: Asia-Pacific Glaucoma Pharmaceuticals Historic
Market Review in US$ Million by End-Use: 2009-2017
Table 111: Asia-Pacific Glaucoma Pharmaceuticals Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
Table 112: Glaucoma Pharmaceuticals Market in Asia-Pacific by
Drug Class: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 113: Asia-Pacific Glaucoma Pharmaceuticals Historic
Market Scenario in US$ Million by Drug Class: 2009-2017
Table 114: Asia-Pacific Glaucoma Pharmaceuticals Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
AUSTRALIA
Table 115: Glaucoma Pharmaceuticals Market in Australia: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2018-2025
Table 116: Australian Glaucoma Pharmaceuticals Market in
Retrospect in US$ Million by End-Use: 2009-2017
Table 117: Glaucoma Pharmaceuticals Market Share Distribution
in Australia by End-Use: 2009 VS 2019 VS 2025
Table 118: Glaucoma Pharmaceuticals Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Drug Class
for the Period 2018-2025
Table 119: Australian Glaucoma Pharmaceuticals Historic Market
Analysis in US$ Million by Drug Class: 2009-2017
Table 120: Australian Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
INDIA
Table 121: Indian Glaucoma Pharmaceuticals Market Quantitative
Demand Analysis in US$ Million by End-Use: 2018 to 2025
Table 122: Glaucoma Pharmaceuticals Market in India:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 123: Indian Glaucoma Pharmaceuticals Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
Table 124: Indian Glaucoma Pharmaceuticals Market Estimates and
Forecasts in US$ Million by Drug Class: 2018 to 2025
Table 125: Indian Glaucoma Pharmaceuticals Historic Market
Review by Drug Class in US$ Million: 2009-2017
Table 126: Glaucoma Pharmaceuticals Market in India: Percentage
Share Breakdown of Sales by Drug Class for 2009, 2019, and 2025
SOUTH KOREA
Table 127: Glaucoma Pharmaceuticals Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
End-Use for the Period 2018-2025
Table 128: South Korean Glaucoma Pharmaceuticals Historic
Market Analysis in US$ Million by End-Use: 2009-2017
Table 129: Glaucoma Pharmaceuticals Market Share Distribution
in South Korea by End-Use: 2009 VS 2019 VS 2025
Table 130: Glaucoma Pharmaceuticals Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by Drug
Class for the Period 2018-2025
Table 131: South Korean Glaucoma Pharmaceuticals Historic
Market Analysis in US$ Million by Drug Class: 2009-2017
Table 132: Glaucoma Pharmaceuticals Market Share Distribution
in South Korea by Drug Class: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 133: Rest of Asia-Pacific Demand Estimates and Forecasts
for Glaucoma Pharmaceuticals in US$ Million by End-Use: 2018 to
2025
Table 134: Rest of Asia-Pacific Glaucoma Pharmaceuticals Market
in US$ Million by End-Use: 2009-2017
Table 135: Glaucoma Pharmaceuticals Market Share Shift in Rest
of Asia-Pacific by End-Use: 2009 VS 2019 VS 2025
Table 136: Rest of Asia-Pacific Market for Glaucoma
Pharmaceuticals: Annual Sales Estimates and Projections in US$
Million by Drug Class for the Period 2018-2025
Table 137: Glaucoma Pharmaceuticals Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Drug
Class for the Period 2009-2017
Table 138: Rest of Asia-Pacific Glaucoma Pharmaceuticals Market
Share Analysis by Drug Class: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 139: Latin American Glaucoma Pharmaceuticals Market
Trends by Region/Country in US$ Million: 2018-2025
Table 140: Glaucoma Pharmaceuticals Market in Latin America in
US$ Million by Region/Country: A Historic Perspective for the
Period 2009-2017
Table 141: Latin American Glaucoma Pharmaceuticals Market
Percentage Breakdown of Sales by Region/Country: 2009, 2019,
and 2025
Table 142: Latin American Demand for Glaucoma Pharmaceuticals
in US$ Million by End-Use: 2018 to 2025
Table 143: Glaucoma Pharmaceuticals Market Review in Latin
America in US$ Million by End-Use: 2009-2017
Table 144: Latin American Glaucoma Pharmaceuticals Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
Table 145: Latin American Glaucoma Pharmaceuticals Market
Growth Prospects in US$ Million by Drug Class for the Period
2018-2025
Table 146: Glaucoma Pharmaceuticals Historic Market Analysis in
Latin America in US$ Million by Drug Class: 2009-2017
Table 147: Latin American Glaucoma Pharmaceuticals Market by
Drug Class: Percentage Breakdown of Sales for 2009, 2019, and
2025
ARGENTINA
Table 148: Argentinean Glaucoma Pharmaceuticals Addressable
Market Opportunity in US$ Million by End-Use: 2018-2025
Table 149: Glaucoma Pharmaceuticals Market in Argentina:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 150: Argentinean Glaucoma Pharmaceuticals Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
Table 151: Argentinean Glaucoma Pharmaceuticals Market
Estimates and Forecasts in US$ Million by Drug Class: 2018-2025
Table 152: Glaucoma Pharmaceuticals Market in Argentina in US$
Million by Drug Class: A Historic Review for the Period
2009-2017
Table 153: Argentinean Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
BRAZIL
Table 154: Glaucoma Pharmaceuticals Quantitative Demand
Analysis in Brazil in US$ Million by End-Use: 2018-2025
Table 155: Brazilian Glaucoma Pharmaceuticals Historic Market
Review in US$ Million by End-Use: 2009-2017
Table 156: Brazilian Glaucoma Pharmaceuticals Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
Table 157: Glaucoma Pharmaceuticals Market in Brazil by Drug
Class: Estimates and Projections in US$ Million for the Period
2018-2025
Table 158: Brazilian Glaucoma Pharmaceuticals Historic Market
Scenario in US$ Million by Drug Class: 2009-2017
Table 159: Brazilian Glaucoma Pharmaceuticals Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
MEXICO
Table 160: Glaucoma Pharmaceuticals Market in Mexico: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2018-2025
Table 161: Mexican Glaucoma Pharmaceuticals Market in
Retrospect in US$ Million by End-Use: 2009-2017
Table 162: Glaucoma Pharmaceuticals Market Share Distribution
in Mexico by End-Use: 2009 VS 2019 VS 2025
Table 163: Glaucoma Pharmaceuticals Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Drug Class
for the Period 2018-2025
Table 164: Mexican Glaucoma Pharmaceuticals Historic Market
Analysis in US$ Million by Drug Class: 2009-2017
Table 165: Mexican Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 166: Rest of Latin America Glaucoma Pharmaceuticals
Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
Table 167: Glaucoma Pharmaceuticals Historic Demand Patterns in
Rest of Latin America by End-Use in US$ Million for 2009-2017
Table 168: Glaucoma Pharmaceuticals Market Share Breakdown in
Rest of Latin America by End-Use: 2009 VS 2019 VS 2025
Table 169: Rest of Latin America Glaucoma Pharmaceuticals
Market Estimates and Projections in US$ Million by Drug Class:
2018 to 2025
Table 170: Glaucoma Pharmaceuticals Market in Rest of Latin
America by Drug Class: A Historic Review in US$ Million for
2009-2017
Table 171: Rest of Latin America Glaucoma Pharmaceuticals
Market Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 172: The Middle East Glaucoma Pharmaceuticals Market
Estimates and Forecasts in US$ Million by Region/Country:
2018-2025
Table 173: Glaucoma Pharmaceuticals Market in the Middle East
by Region/Country in US$ Million: 2009-2017
Table 174: The Middle East Glaucoma Pharmaceuticals Market
Share Breakdown by Region/Country: 2009, 2019, and 2025
Table 175: The Middle East Glaucoma Pharmaceuticals Market
Quantitative Demand Analysis in US$ Million by End-Use: 2018 to
2025
Table 176: Glaucoma Pharmaceuticals Market in the Middle East:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 177: The Middle East Glaucoma Pharmaceuticals Market
Share Analysis by End-Use: 2009 VS 2019 VS 2025
Table 178: The Middle East Glaucoma Pharmaceuticals Market
Estimates and Forecasts in US$ Million by Drug Class: 2018 to
2025
Table 179: The Middle East Glaucoma Pharmaceuticals Historic
Market by Drug Class in US$ Million: 2009-2017
Table 180: Glaucoma Pharmaceuticals Market in the Middle East:
Percentage Share Breakdown of Sales by Drug Class for 2009,
2019, and 2025
IRAN
Table 181: Iranian Demand Estimates and Forecasts for Glaucoma
Pharmaceuticals in US$ Million by End-Use: 2018 to 2025
Table 182: Iranian Glaucoma Pharmaceuticals Market in US$
Million by End-Use: 2009-2017
Table 183: Glaucoma Pharmaceuticals Market Share Shift in Iran
by End-Use: 2009 VS 2019 VS 2025
Table 184: Iranian Market for Glaucoma Pharmaceuticals: Annual
Sales Estimates and Projections in US$ Million by Drug Class
for the Period 2018-2025
Table 185: Glaucoma Pharmaceuticals Market in Iran: Historic
Sales Analysis in US$ Million by Drug Class for the Period
2009-2017
Table 186: Iranian Glaucoma Pharmaceuticals Market Share
Analysis by Drug Class: 2009 VS 2019 VS 2025
ISRAEL
Table 187: Israeli Glaucoma Pharmaceuticals Addressable Market
Opportunity in US$ Million by End-Use: 2018-2025
Table 188: Glaucoma Pharmaceuticals Market in Israel:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 189: Israeli Glaucoma Pharmaceuticals Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
Table 190: Israeli Glaucoma Pharmaceuticals Market Estimates
and Forecasts in US$ Million by Drug Class: 2018-2025
Table 191: Glaucoma Pharmaceuticals Market in Israel in US$
Million by Drug Class: A Historic Review for the Period
2009-2017
Table 192: Israeli Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 193: Saudi Arabian Demand for Glaucoma Pharmaceuticals in
US$ Million by End-Use: 2018 to 2025
Table 194: Glaucoma Pharmaceuticals Market Review in Saudi
Arabia in US$ Million by End-Use: 2009-2017
Table 195: Saudi Arabian Glaucoma Pharmaceuticals Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
Table 196: Saudi Arabian Glaucoma Pharmaceuticals Market Growth
Prospects in US$ Million by Drug Class for the Period 2018-2025
Table 197: Glaucoma Pharmaceuticals Historic Market Analysis in
Saudi Arabia in US$ Million by Drug Class: 2009-2017
Table 198: Saudi Arabian Glaucoma Pharmaceuticals Market by
Drug Class: Percentage Breakdown of Sales for 2009, 2019, and
2025
UNITED ARAB EMIRATES
Table 199: Glaucoma Pharmaceuticals Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by End-Use for the Period 2018-2025
Table 200: United Arab Emirates Glaucoma Pharmaceuticals
Historic Market Analysis in US$ Million by End-Use: 2009-2017
Table 201: Glaucoma Pharmaceuticals Market Share Distribution
in United Arab Emirates by End-Use: 2009 VS 2019 VS 2025
Table 202: Glaucoma Pharmaceuticals Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Drug Class for the Period 2018-2025
Table 203: United Arab Emirates Glaucoma Pharmaceuticals
Historic Market Analysis in US$ Million by Drug Class:
2009-2017
Table 204: Glaucoma Pharmaceuticals Market Share Distribution
in United Arab Emirates by Drug Class: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 205: Glaucoma Pharmaceuticals Market in Rest of Middle
East: Annual Sales Estimates and Forecasts in US$ Million by
End-Use for the Period 2018-2025
Table 206: Rest of Middle East Glaucoma Pharmaceuticals Market
in Retrospect in US$ Million by End-Use: 2009-2017
Table 207: Glaucoma Pharmaceuticals Market Share Distribution
in Rest of Middle East by End-Use: 2009 VS 2019 VS 2025
Table 208: Glaucoma Pharmaceuticals Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Drug Class for the Period 2018-2025
Table 209: Rest of Middle East Glaucoma Pharmaceuticals
Historic Market Analysis in US$ Million by Drug Class:
2009-2017
Table 210: Rest of Middle East Glaucoma Pharmaceuticals Market
Share Breakdown by Drug Class: 2009 VS 2019 VS 2025
AFRICA
Table 211: African Glaucoma Pharmaceuticals Latent Demand
Forecasts in US$ Million by End-Use: 2018 to 2025
Table 212: Glaucoma Pharmaceuticals Historic Demand Patterns in
Africa by End-Use in US$ Million for 2009-2017
Table 213: Glaucoma Pharmaceuticals Market Share Breakdown in
Africa by End-Use: 2009 VS 2019 VS 2025
Table 214: African Glaucoma Pharmaceuticals Market Estimates
and Projections in US$ Million by Drug Class: 2018 to 2025
Table 215: Glaucoma Pharmaceuticals Market in Africa by Drug
Class: A Historic Review in US$ Million for 2009-2017
Table 216: African Glaucoma Pharmaceuticals Market Share
Breakdown by Drug Class: 2009 VS 2019 VS 2025

IV. COMPETITION

AERIE PHARMACEUTICALS
ALLERGAN PLC
MERCK & CO., INC.
NOVARTIS INTERNATIONAL AG
PFIZER
SANTEN PHARMACEUTICAL

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05817992/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
Distribution channels: Media, Advertising & PR


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.